March 30, 2017 / 8:41 AM / 5 months ago

BRIEF-Shenzhen Hepalink Pharmaceutical sees Q1 FY 2017 net loss to be 10 mln yuan to 30 mln yuan

March 30 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd :

* Sees Q1 FY 2017 net loss to be 10 million yuan to 30 million yuan

* Says Q1 FY 2016 net profit was 195.9 million yuan

* The reasons for the forecast are decreased sales revenue and investment return and increased material price and financial expense

Source text in Chinese: goo.gl/9H4dLK

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below